Ignite Creation Date:
2024-05-06 @ 3:49 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02382471
Status:
COMPLETED
Last Update Posted:
2015-03-06
First Post:
2015-02-16
Brief Title:
Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF Follistatin Irisin Levels in Men With CAD
Sponsor:
Tehran University of Medical Sciences
Organization:
Tehran University of Medical Sciences
Study Overview
Official Title:
Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF Follistatin Irisin Levels in Men With Coronary Artery Disease
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is the comparison between the effects of supplementation with omega 3 or placebo for 8 weeks in serum level of BDNF Follistatin Irisin in patients with cardiovascular disease
Detailed Description:
The aim of this study is the comparison between the effects of supplementation with omega 3 or placebo for 8 weeks in serum level of BDNF Follistatin Irisin in patients with cardiovascular disease In this randomized double-blind clinical trial placebo-controlled single-center and phase two trials 42men aged 45-65 years with Coronary Artery Disease are enrolled in the study from Tehran Heart Center After signing informed consent all individuals complete a general information form 24-hour food recall for 3 days will be taken from the participants at the beginning and the end of the study Selected samples are randomly classified into 2 blocks of groups receiving supplement and placebo The supplement group will receive 4 gday omega 3 fatty acid for 8 weeks and the placebo group will also receive placebo containing 4 g of edible paraffin similar in terms of color shape and size Patients are recommended to sustain their diets and medication dose s during the study and also advised to maintain a constant level of physical activity Blood samples will be collected after 8-12 hours fasting and anthropometric variables biochemical parameters and physical activity before and after the trial will be measured
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None